NYSE Euronext Bid Puts 2012 on ICE

Earlier this week, at a meeting inside the building directly south of NYSE Euronext's US head offices, Emmanuel Carjat, manager director of infrastructure provider TMX Atrium, spoke about the outlook for 2013. He suggested that if equities transactions were to continue their slump into 2013, some kind of consolidation would, as a basic matter of operating costs, become imperative—despite the failed attempts at it this year.
Carjat might be clairvoyant, or just good at reading tea leaves. With the announcement of IntercontinentalExchange's acquisition of NYSE Euronext just hours ago, he seems only to have underestimated the exchange operators' urgency.
Apparently the NYSE Euronext–Deutsche Börse debacle, and this year's slipping volumes, were enough.
Regulators or competing exchanges could still attempt to block the deal, but the match this time seems fairly straightforward, and a good fit in terms of the exchange operators’ innate strengths as well as antitrust concerns. ICE has been described as an "upstart market operator,” but considering the Atlanta-based firm's growth since its launch in 2000, that is selling it short. But the sentiment is important as it seeks to get the deal pushed through and for now, "upstart" ICE is likely quite fine with CEO Jeffery Sprecher.
In the meantime, a few technology-related thoughts come to mind. If it wasn't already clear, equities is now second, if not third, to commodities and fixed-income derivatives trading in terms of the markets' forward outlook. Technology is not entirely to blame, but it has played a part—think high-frequency trading (HFT) sharks and well-publicized systems errors like those at Knight Capital—in chasing away retail and institutional investors alike. That, Carjat points out, is a problem no matter who the ultimate owner of the NYSE is.
Meanwhile, the value attached to expertise in derivatives, and particularly swaps, has ballooned during the year's creeping implementation of Dodd–Frank. From swaps execution, to post-trade processing and clearing in both established and emerging markets, ICE's Creditex and Credit Clear have been right out in front, and the firm has made few bones about registering as and building out a swap execution facility (SEF), where others have been more hesitant.
Finally ICE's original specialty, facilitating trading and hedging in commodities futures and options, has proven highly sustainable.
Put all that together—a potentially undervalued NYSE Euronext, regulatory capital, a solid foundation, and the drive to become truly "intercontinental"—and the justification for having a try at this deal now makes quite a bit of sense. Assuming the deal is approved, it will be fascinating to see how, if at all, the firms integrate their platforms and technology strategies.
Along those lines, two questions stand out. First, how will ICE's clearing, and the cleaing landscape more broadly, evolve? Remember that NYSE Liffe—the London derivatives market said to be a coveted asset in the ICE takeover bid—announced in June it would part ways with LCH.Clearnet in 2013 to build its own operation. A separate announcement today brought some early clarity, saying Liffe's execution and clearing will now be handled through ICE Clear Europe, with the combined operation set to ramp up rate swaps clearing.
Second, what are ICE’s plans for NYSE Technologies, which earlier in the year saw CEO Stanley Young depart for Bloomberg, replaced by Thomson Reuters veteran Jon Robson?
And finally, what does this portend for merger and acquisition (M&A) activity in 2013? One can only hope it is a clear signal that the market sees good things on the horizon.
In the wake of so many botched, blocked and rebuffed mergers in the shifting exchange landscape, this one seems, at least for now, to have gotten it right.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.
AI fails for many reasons but succeeds for few
Firms hoping to achieve ROI on their AI efforts must focus on data, partnerships, and scale—but a fundamental roadblock remains.
Waters Wavelength Ep. 330: AI hot takes
It’s Shen and Reb this week talking about AI and the landscape for fintech partnerships.